摘要
目的:实现对轻度认知功能障碍(MCI)的不同研究结果进行有意义的比较,这对于选择一个适当的客观记忆测试方法来检验记忆缺陷很关键。我们旨在完善遗忘型轻度认知功能障碍(aMCI)的神经心理学测试最佳平衡敏感性和特异性的操作标准。方法:样本来源于记忆门诊的206例非痴呆患者。然后我们根据不同的神经心理标准将个体分类为MCI或主观认知能力下降(SCD)。通过纵向比较,临床疗效评价MCI诊断和预测疾病进展的稳定性。结果:听觉言语学习的回忆延迟测验(AVLT_DR)确定的116例MCI,结果显示在30个月的间隔期内转化率达44%,除7.8%的患者,SCD组早期阿尔茨海默病(AD)患者最终均转化为痴呆。与AVLT标准相比,复杂图形回忆延迟测试(CFT_DR)确诊了较少的MCI患者(n = 95)和误诊了更多的临床前AD患者(15.3%)。在这两个测试中的标准要求缺陷导致了较高的转化率(54.3%),同时也导致较高的误诊率(14.7%)。AVLT标准曲线下面积最大(0.7248,p < 0.05)。结论:AVLT在诊断和预测疾病进展的稳定性优于CFT。在临床上,“一项测验”标准都有类似的缺陷AVLT方法灵敏度,和最佳平衡的敏感性和特异性。
关键词: 阿茨海默氏症,听觉言语学习测试,轻度认知功能障碍,操作标准,Rey-Osterrieth复杂图形测验,主观认知减退。
Current Alzheimer Research
Title:Auditory Verbal Learning Test is Superior to Rey-Osterrieth Complex Figure Memory for Predicting Mild Cognitive Impairment to Alzheimer’s Disease
Volume: 12 Issue: 6
Author(s): Qianhua Zhao, Qihao Guo, Xiaoniu Liang, Meirong Chen, Yan Zhou, Ding Ding and Zhen Hong
Affiliation:
关键词: 阿茨海默氏症,听觉言语学习测试,轻度认知功能障碍,操作标准,Rey-Osterrieth复杂图形测验,主观认知减退。
摘要: Objective: To carry out meaningful comparisons on results of different research studies on mild cognitive impairment (MCI), it is critical to select an appropriate objective memory test to examine memory deficit. We aim to refine the operational criteria of amnestic MCI (aMCI) on neuropsychological tests that optimally balance the sensitivity and specificity. Methods: We focused on 206 non-demented subjects from memory clinic. We then classified each individual as having MCI or subjective cognitive decline (SCD) according to different neuropsychological criteria. By following them longitudinally, clinical outcomes were compared to evaluate the stability of MCI diagnoses and prediction of progression. Results: The delayed recall of auditory verbal learning test (AVLT_DR) identified 116 subjects as MCI, resulted in the conversion rate as 44% over the roughly 30-month time interval, missed 7.8% incipient Alzheimer’s disease (AD) patients in SCD group who eventually converted to dementia. The delayed recall of complex figure test (CFT_DR) identified fewer MCI patients (n=95) and misdiagnosed more preclinical AD patients (15.3%), in comparison with AVLT criterion. Criterion requiring deficits in both tests produced higher conversion rate (54.3%), but resulted in higher misdiagnosis rate (14.7%) simultaneously. The AVLT criterion had the largest area under the curve (0.7248, p<0.05). Conclusion: AVLT is superior to CFT in the stability of diagnoses and prediction of progression. In the clinical setting, the “one test” criterion AVLT has similar sensitivity to both-deficits methods, and is optimal in balancing sensitivity and specificity.
Export Options
About this article
Cite this article as:
Qianhua Zhao, Qihao Guo, Xiaoniu Liang, Meirong Chen, Yan Zhou, Ding Ding and Zhen Hong , Auditory Verbal Learning Test is Superior to Rey-Osterrieth Complex Figure Memory for Predicting Mild Cognitive Impairment to Alzheimer’s Disease, Current Alzheimer Research 2015; 12 (6) . https://dx.doi.org/10.2174/1567205012666150530202729
DOI https://dx.doi.org/10.2174/1567205012666150530202729 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Dynamic Role of Macrophage Sub Types on Development of Atherosclerosis
and Potential Use of Herbal Immunomodulators as Imminent
Therapeutic Strategy
Cardiovascular & Hematological Agents in Medicinal Chemistry Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors
Current Neurovascular Research Cellular Protection and Therapeutic Potential of Tocotrienols
Current Pharmaceutical Design Central Selective Acetylcholinesterase Inhibitor with Neurotrophic Activity Structure-Activity Relationships of TAK-147 and Related Compounds
Current Medicinal Chemistry Definition of Genes and Paths Involved in Alzheimers Disease: Using Gene Expression Profiles and Chemical Genetics at the Mouse Brain Level
Current Genomics Statin Treatment and the Natural History of Atherosclerotic-Related Diseases: Pathogenic Mechanisms and the Risk-Benefit Profile
Current Pharmaceutical Design Gene Therapy and Cell Reprogramming For the Aging Brain: Achievements and Promise
Current Gene Therapy An Update on Drug Interactions with the Herbal Medicine Ginkgo biloba
Current Drug Metabolism Defects in RNA Metabolism links FTD and ALS Pathogenesis: TDP-43, FUS, and C9orf72
Current Enzyme Inhibition Circulating Biochemical Markers of Brain Damage in Infants Complicated by Ischemia Reperfusion Injury
Cardiovascular & Hematological Agents in Medicinal Chemistry Role of the Sex Hormone Estrogen in the Prevention of Lipid Disorder
Current Medicinal Chemistry Diffuse Correlation Spectroscopy (DCS): A Diagnostic Tool for Assessing Tissue Blood Flow in Vascular-Related Diseases and Therapies
Current Medical Imaging Virus Vasculopathy and Stroke: An Under-Recognized Cause and Treatment Target
Infectious Disorders - Drug Targets Micro-RNA in Disease and Gene Therapy
Current Drug Discovery Technologies Recent Developments in Computer Aided Diagnosis for Lung Nodule Detection from CT images: A Review
Current Medical Imaging Hyperhomocysteinemia and Cardiovascular Risk: Effect of Vitamin Supplementation in Risk Reduction
Current Clinical Pharmacology Anticancer Agents: VTA or VDA
Current Bioactive Compounds Neonatal Atlas Templates for the Study of Brain Development Using Magnetic Resonance Images
Current Medical Imaging Novel Target Sites for Drug Screening: A Special Reference to Cancer, Rheumatoid Arthritis and Parkinson’s Disease
Current Signal Transduction Therapy Diagnostic Value of the Early Heart-to-Mediastinum Count Ratio in Cardiac 123I-mIBG Imaging for Parkinson's Disease
Current Radiopharmaceuticals